were extremely frequent. Fifty-three percent of patients reported side effects. Most frequent were hypotension (10%), peripheral edema (14%) and non-specific edema (2%). Arrhythmias were encountered in dostinex sideffects palpitations in dostinex sideffects and angina pectoris in 1.4%.In a combinatiion study with 2,000 patients also treated with levodopa, the incidence.

disease.[2][3] Both drugs are ergot-derived dopamine agonists, although their molecular skeletons are different. dostinex sideffects a result dostinex sideffects this, the FDA removed pergolide from the combination.[edit] DosageParkinson's disease: Monotherapy: Initial dose should be dostinex sideffects mg per week, slowly titrated to 4.5 mg per week, slowly titrated to 4.5 mg per week, if necessary.Ablactation: According to specific treatment scheme.[edit] References^ Dostinex at www.rxlist.com. Retrieved on 2007-04-27. CabergolineFrom Wikipedia, the free encyclopedia(Redirected from Dostinex)Jump to: navigation, searchCabergolineSystematic (IUPAC) nameN-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]- 6-(2-propenyl)-8g-ergoline-8-carboxamideor1-[(6-allylergolin8?-yl)- carbonyl]-1- [3-(dimethylamino)propyl]-3-ethylureaIdentifiersCAS number dostinex sideffects dostinex sideffects G02CB03 N04BC06PubChem 54746DrugBank APRD00836Chemical dataFormula C26H37N5O2Mol. mass 451.604 g/molPharmacokinetic dataBioavailability First-pass effect seen; absolute bioavailability unknownProtein.

and hallucinations (4%).Cardiovascular: Approximately 30 percent of patients experienced side effects. Very frequent: Sleep disturbances.